These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 28179589)

  • 1. Targeting the equilibrative nucleoside transporter ENT1 in Huntington disease.
    Guitart X; Chern Y; Ferré S
    Oncotarget; 2017 Feb; 8(8):12550-12551. PubMed ID: 28179589
    [No Abstract]   [Full Text] [Related]  

  • 2. Equilibrative nucleoside transporter ENT1 as a biomarker of Huntington disease.
    Guitart X; Bonaventura J; Rea W; Orrú M; Cellai L; Dettori I; Pedata F; Brugarolas M; Cortés A; Casadó V; Chang CP; Narayanan M; Chern Y; Ferré S
    Neurobiol Dis; 2016 Dec; 96():47-53. PubMed ID: 27567601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting ENT1 and adenosine tone for the treatment of Huntington's disease.
    Kao YH; Lin MS; Chen CM; Wu YR; Chen HM; Lai HL; Chern Y; Lin CJ
    Hum Mol Genet; 2017 Feb; 26(3):467-478. PubMed ID: 28069792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dilazep analogues for the study of equilibrative nucleoside transporters 1 and 2 (ENT1 and ENT2).
    Playa H; Lewis TA; Ting A; Suh BC; Muñoz B; Matuza R; Passer BJ; Schreiber SL; Buolamwini JK
    Bioorg Med Chem Lett; 2014 Dec; 24(24):5801-5804. PubMed ID: 25454272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Affinity, binding kinetics and functional characterization of draflazine analogues for human equilibrative nucleoside transporter 1 (SLC29A1).
    Vlachodimou A; Konstantinopoulou K; IJzerman AP; Heitman LH
    Biochem Pharmacol; 2020 Feb; 172():113747. PubMed ID: 31830468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new drug design targeting the adenosinergic system for Huntington's disease.
    Huang NK; Lin JH; Lin JT; Lin CI; Liu EM; Lin CJ; Chen WP; Shen YC; Chen HM; Chen JB; Lai HL; Yang CW; Chiang MC; Wu YS; Chang C; Chen JF; Fang JM; Lin YL; Chern Y
    PLoS One; 2011; 6(6):e20934. PubMed ID: 21713039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleoside and nucleobase transporters of primary human cardiac microvascular endothelial cells: characterization of a novel nucleobase transporter.
    Bone DB; Hammond JR
    Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3325-32. PubMed ID: 17921321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 1 equilibrative nucleoside transporter regulates astrocyte-specific glial fibrillary acidic protein expression in the striatum.
    Hinton DJ; Lee MR; Jang JS; Choi DS
    Brain Behav; 2014; 4(6):903-14. PubMed ID: 25365803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation of leucine-92 selectively reduces the apparent affinity of inosine, guanosine, NBMPR [S6-(4-nitrobenzyl)-mercaptopurine riboside] and dilazep for the human equilibrative nucleoside transporter, hENT1.
    Endres CJ; Sengupta DJ; Unadkat JD
    Biochem J; 2004 May; 380(Pt 1):131-7. PubMed ID: 14759222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosinergic regulation of striatal clock gene expression and ethanol intake during constant light.
    Ruby CL; Vadnie CA; Hinton DJ; Abulseoud OA; Walker DL; O'Connor KM; Noterman MF; Choi DS
    Neuropsychopharmacology; 2014 Sep; 39(10):2432-40. PubMed ID: 24755889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation of Trp29 of human equilibrative nucleoside transporter 1 alters affinity for coronary vasodilator drugs and nucleoside selectivity.
    Paproski RJ; Visser F; Zhang J; Tackaberry T; Damaraju V; Baldwin SA; Young JD; Cass CE
    Biochem J; 2008 Sep; 414(2):291-300. PubMed ID: 18462193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine transporter ENT1 regulates the acquisition of goal-directed behavior and ethanol drinking through A2A receptor in the dorsomedial striatum.
    Nam HW; Hinton DJ; Kang NY; Kim T; Lee MR; Oliveros A; Adams C; Ruby CL; Choi DS
    J Neurosci; 2013 Mar; 33(10):4329-38. PubMed ID: 23467349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological analysis and molecular cloning of the canine equilibrative nucleoside transporter 1.
    Hammond JR; Stolk M; Archer RG; McConnell K
    Eur J Pharmacol; 2004 Apr; 491(1):9-19. PubMed ID: 15102528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the ENT1 antagonists dipyridamole and dilazep as amplifiers of oncolytic herpes simplex virus-1 replication.
    Passer BJ; Cheema T; Zhou B; Wakimoto H; Zaupa C; Razmjoo M; Sarte J; Wu S; Wu CL; Noah JW; Li Q; Buolamwini JK; Yen Y; Rabkin SD; Martuza RL
    Cancer Res; 2010 May; 70(10):3890-5. PubMed ID: 20424118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the adenosine pharmacology of ticagrelor reveals therapeutically relevant inhibition of equilibrative nucleoside transporter 1.
    Armstrong D; Summers C; Ewart L; Nylander S; Sidaway JE; van Giezen JJ
    J Cardiovasc Pharmacol Ther; 2014 Mar; 19(2):209-19. PubMed ID: 24414167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycine 154 of the equilibrative nucleoside transporter, hENT1, is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine, dipyridamole, and dilazep.
    SenGupta DJ; Unadkat JD
    Biochem Pharmacol; 2004 Feb; 67(3):453-8. PubMed ID: 15037197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular cloning and functional characterization of inhibitor-sensitive (mENT1) and inhibitor-resistant (mENT2) equilibrative nucleoside transporters from mouse brain.
    Kiss A; Farah K; Kim J; Garriock RJ; Drysdale TA; Hammond JR
    Biochem J; 2000 Dec; 352 Pt 2(Pt 2):363-72. PubMed ID: 11085929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astrocytic equilibrative nucleoside transporter type 1 upregulations in the dorsomedial and dorsolateral striatum distinctly coordinate goal-directed and habitual ethanol-seeking behaviours in mice.
    Hong SI; Bullert A; Baker M; Choi DS
    Eur J Neurosci; 2020 Aug; 52(3):3110-3123. PubMed ID: 32306482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of novel dual-action compounds targeting the adenosine A(2A) receptor and adenosine transporter for neuroprotection.
    Chen JB; Liu EM; Chern TR; Yang CW; Lin CI; Huang NK; Lin YL; Chern Y; Lin JH; Fang JM
    ChemMedChem; 2011 Aug; 6(8):1390-400. PubMed ID: 21692183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structures of human ENT1 in complex with adenosine reuptake inhibitors.
    Wright NJ; Lee SY
    Nat Struct Mol Biol; 2019 Jul; 26(7):599-606. PubMed ID: 31235912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.